Author's Reply to Wendling and Prati: "Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs"

被引：0
|
作者：
Wei, James Cheng-Chung [1 ,2 ,3 ]
机构：
[1] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan
[3] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
来源：
DRUGS | 2014年 / 74卷 / 14期
关键词：
ANKYLOSING-SPONDYLITIS; PSORIATIC-ARTHRITIS; ADALIMUMAB;
D O I：
10.1007/s40265-014-0289-2
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1717 / 1718
页数：2
相关论文
共 50 条
  • [41] Efficacy of the treat-to-target approach in modifying disease course with ustekinumab in patients with moderate-to-severe Crohn's Disease: Results from the STARDUST trial
    Peyrin-Biroulet, L.
    Vermeire, S.
    D'Haens, G. R.
    Panes, J.
    Dignass, A.
    Magro, F.
    Le Bars, M.
    Lahaye, M.
    Nazar, M.
    Ni, L.
    Bravata, I.
    Lavie, F.
    Daperno, M.
    Lukas, M.
    Armuzzi, A.
    Lowenberg, M.
    Gaya, D. R.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I132 - I134
  • [42] Core liver homeostatic networks: implications in therapeutic target discovery, pre-clinical studies, and innovative trial designs
    Esmaili, Saeed
    George, Jacob
    JOURNAL OF HEPATOLOGY, 2021, 75 : S607 - S608
  • [43] Author's reply: "The importance of properly specifying your target trial emulation: commentary on Mesidor et al."
    Mesidor, Miceline
    Sirois, Caroline
    Robert, Jason
    Poirier, Paul
    Blais, Claudia
    Talbot, Denis
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2025, 180
  • [44] Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial
    Raft, M. B.
    Hetland, M. L.
    Brahe, C. H.
    Horslev-Petersen, K.
    Midtboll Ornbjerg, L.
    Junker, P.
    Biln, N.
    Stengaard-Pedersen, K.
    Ostergaard, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 (04) : 342 - 352
  • [45] Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial
    Rodbard, Helena W.
    Visco, Virginia E.
    Andersen, Henning
    Hiort, Line C.
    Shu, David H. W.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (01): : 30 - 37
  • [46] Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis The IMAGINE-RA Randomized Clinical Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ejbjerg, Bo
    Hetland, Merete Lund
    Ornbjerg, Lykke Midtboll
    Glinatsi, Daniel
    Moller, Jakob
    Boesen, Mikael
    Christensen, Robin
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Hendricks, Oliver
    Asmussen, Karsten
    Kowalski, Marcin
    Lindegaard, Hanne
    Nielsen, Sabrina Mai
    Bliddal, Henning
    Krogh, Niels Steen
    Ellingsen, Torkell
    Nielsen, Agnete H.
    Balding, Lone
    Jurik, Anne Grethe
    Thomsen, Henrik S.
    Ostergaard, Mikkel
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (05): : 461 - 472
  • [47] AN MRI GUIDED TREAT-TO-TARGET STRATEGY IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION IMPROVED MRI INFLAMMATION BUT NOT DAMAGE PROGRESSION - RESULTS FROM THE IMAGINE-RA RANDOMISED CONTROLLED TRIAL
    Moller-Bisgaard, S.
    Horslev-Pedersen, K.
    Ejbjerg, B.
    Glinatsi, D.
    Hetland, M.
    Ornbjerg, L.
    Moller, J.
    Boesen, M.
    Christensen, R.
    Stengaard-Pedersen, K.
    Madsen, O. R.
    Jensen, B.
    Villadsen, J.
    Hauge, E. -M.
    Bennett, P.
    Hendricks, O.
    Asmussen, K.
    Kowalski, M.
    Lindegaard, H.
    Nielsen, S. M.
    Bliddal, H.
    Krogh, N.
    Ellingsen, T.
    Nielsen, A. H.
    Balding, L.
    Jurik, A. G.
    Thomsen, H.
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 126 - 126
  • [48] An MRI Guided Treat-to-Target Strategy in Rheumatoid Arthritis Patients in Clinical Remission Improved MRI Inflammation but Not Damage Progression - Results from the Imagine-RA Randomized Controlled Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ejbjerg, Bo Jannik
    Glinatsi, Daniel
    Hetland, Merete Lund
    Ornbjerg, Lykke
    Moller, Jakob M.
    Boesen, Mikael
    Christensen, Robin
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Bennett, Philip
    Hendricks, Oliver
    Asmussen, Karsten
    Kowalski, Marcin Ryszard
    Lindegaard, Hanne
    Nielsen, Sabrina Mai
    Bliddal, Henning
    Krogh, Niels Steen
    Ellingsen, Torkell
    Nielsen, Agente
    Balding, Lone
    Jurik, Anne Grethe
    Thomsen, Henrik S.
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [49] Clinical implications of urine output-based sepsis-associated acute kidney injury. Author's reply
    White, Kyle C.
    Laupland, Kevin B.
    Tabah, Alexis
    Ramanan, Mahesh
    Bellomo, Rinaldo
    INTENSIVE CARE MEDICINE, 2023, 49 (10) : 1266 - 1267
  • [50] Clinical implications of urine output-based sepsis-associated acute kidney injury. Author’s reply
    Kyle C. White
    Kevin B. Laupland
    Alexis Tabah
    Mahesh Ramanan
    Rinaldo Bellomo
    Intensive Care Medicine, 2023, 49 : 1266 - 1267
12345